Immucell corp /de/ (ICCC)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Product sales

13,722

10,986

10,431

9,543

10,228

7,596

6,007

5,389

5,111

4,386

4,505

Costs of goods sold

6,983

5,792

5,209

4,123

3,977

3,147

2,946

2,335

2,297

2,083

2,107

Gross margin

6,739

5,193

5,221

5,420

6,250

4,449

3,060

3,054

2,813

2,302

2,398

OPERATING EXPENSES (INCOME):
Product development expenses

3,687

3,516

2,046

1,244

1,235

2,179

1,154

917

1,720

1,492

1,644

Sales and marketing expenses

2,318

2,084

1,892

1,831

1,606

1,317

986

973

869

650

410

Administrative expenses

1,687

1,738

1,524

1,454

1,286

1,159

939

918

856

849

872

Gain on sale of assets

-

700

-

-

-

-

-

-

-

-

-

Operating activities, net

7,693

6,640

5,464

4,530

4,128

4,655

3,080

2,809

3,446

2,992

2,927

NET OPERATING INCOME

-953

-1,446

-242

890

2,122

-206

-19

245

-632

-690

-529

Other expenses, net

313

413

195

131

58

49

-224

52

63

-6

101

(LOSS) INCOME BEFORE INCOME TAXES

-1,267

-1,860

-438

758

2,063

-255

205

192

-696

-683

-428

Income tax (benefit) expense

28

461

-270

249

850

-88

87

102

-287

-298

-212

NET (LOSS) INCOME

-1,295

-2,321

-168

508

1,213

-167

117

89

-409

-384

-216

Weighted average common shares outstanding:
Basic weighted average common shares outstanding

6,818

5,486

4,949

4,225

3,042

3,027

3,019

3,018

2,984

2,970

2,958

NET (LOSS) INCOME PER SHARE:
Basic net (loss) income per share

-0.19

-0.42

-0.03

0.12

0.40

-0.06

0.04

0.03

-0.14

-0.13

-0.07

Diluted weighted average common shares outstanding

6,818

5,486

4,949

4,336

3,165

3,027

3,085

3,108

2,984

2,970

2,958

Diluted net (loss) income per share

-0.19

-0.42

-0.03

0.12

0.38

-0.06

0.04

0.03

-0.14

-0.13

-0.07